AIIMS, ICMR begin multi-centre trial on HPV tests for detecting cervical cancer

Written By :  Kajal Rajput
Medically Reviewed By :  Dr. Kamal Kant Kohli
Published On 2024-01-28 04:00 GMT   |   Update On 2024-03-26 08:19 GMT
Advertisement

New Delhi: AIIMS Delhi and the Indian Council of Medical Research have started a multi-centre trial to evaluate three indigenous human papillomavirus tests for detecting cervical cancer so that they meet international quality standards, a senior doctor said on Thursday. 

The trial began on January 22 and aims to develop an accurate and affordable test which can be integrated into the National Cancer Screening Programme, Dr Neerja Bhatla, Head of Department of Obstetrics and Gynaecology at AIIMS said.

Advertisement

"The present indigenous tests available have not yet been validated for conformity with international standards," she said.

Also Read:Dual ICMR Recognition: Amrita Hospital, Kochi, Bags now Centre of Excellence in Groundbreaking Snakebite and Paediatric Cardiac Research

The Visual Inspection with Acetic Acid (VIA) test for cancer detection which has a risk of false positive is being used under the national programme currently and it is not accurate, Bhatla said.

To validate these tests, the Biotechnology Industry Research Assistance Council (BIRAC) has collaborated with WHO's International Agency for Research on Cancer (IARC). The agency would be providing around 12,00 samples for testing, she said.

The three HPV tests will be conducted at three separate laboratories of the All India Institute of Medical Sciences (AIIMS), the National Institute of Cancer Prevention Research in Noida and the National Institute for Research in Reproductive and Child Health in Mumbai, she said.

Meanwhile, doctors have said that women over the age of 30 should get screened periodically for cervical cancer through HPV, Pap or VIA tests.

They also recommended that young girls should get the HPV vaccine preferably before the age of 15 years.

Medical Dialogues team had earlier reported that the Union Health Ministry said it has yet to take a decision on the roll-out of HPV vaccination against cervical cancer in the country. Dismissing media reports on the vaccination campaign, the ministry said it is closely monitoring cervical cancer cases in the country and is in regular touch with states and various health departments.  

Tags:    

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News